Literature DB >> 33226538

Continuous wavelet transform analysis of ERG in patients with diabetic retinopathy.

Hamid Ahmadieh1, Soroor Behbahani2, Sare Safi3.   

Abstract

PURPOSE: Diabetic retinopathy (DR) is one of the leading causes of blindness worldwide. Non-proliferative diabetic retinopathy (NPDR) is a stage of the disease that contains morphological and functional disruption of the retinal vasculature and dysfunction of retinal neurons. This study aimed to compare time and time-frequency-domain analysis in the evaluation of electroretinograms (ERGs) in subjects with NPDR.
METHOD: The ERG responses were recorded in 16 eyes from 12 patients with NPDR and 24 eyes from 12 healthy subjects as the control group. The implicit time, amplitude, and time-frequency-domain parameters of photopic and scotopic ERGs were analyzed.
RESULTS: The implicit times of b-waves in the dark-adapted 10.0 (P = 0.0513) and light-adapted 3.0 (P = 0.0414) were significantly increased in the NPDR group. The amplitudes of a- and b-wave showed a significantly decreased dark-adapted 10.0 (P = 0.0212; P = 0.0133) and light-adapted 3.0 (P = 0.0517; P = 0.0021) ERG of the NPDR group. The Cohen's d effect size had higher values in the amplitude of dark-adapted 10.0 b-wave (|d|= 1.8058) and amplitude of light-adapted 3.0 b-wave (|d|= 1.9662). The CWT results showed that the frequency ranges of the dominant components in dark-adapted 10.0 and light-adapted 3.0 ERG were decreased in the NPDR group compared to the healthy group (P < 0.05). The times associated with the NDPR group's dominant components were increased compared to normal eyes in both dark-adapted 10.0 and light-adapted 3.0 ERG (P < 0.05). All Cohen's d effect sizes of the implicit times and dominant frequency components were on a large scale (|d|> 1).
CONCLUSION: These findings suggest that the time and time-frequency parameters of both photopic and scotopic ERGs can be good indicators for DR. However, time-frequency-domain analysis could present more information might be helpful in the assessment of the DR severity.

Entities:  

Keywords:  Continuous wavelet transform; Diabetic retinopathy; Dominant frequency; Electroretinogram

Mesh:

Year:  2020        PMID: 33226538     DOI: 10.1007/s10633-020-09805-9

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  38 in total

Review 1.  Diabetic retinopathy.

Authors:  Ning Cheung; Paul Mitchell; Tien Yin Wong
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

Review 2.  Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

Authors:  A Hutchinson; A McIntosh; J Peters; C O'Keeffe; K Khunti; R Baker; A Booth
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

3.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

4.  Photopic electroretinogram implicit time in diabetic retinopathy.

Authors:  S Satoh; H Iijima; M Imai; K Abe; T Shibuya
Journal:  Jpn J Ophthalmol       Date:  1994       Impact factor: 2.447

5.  Temporal aspects of the electroretinogram in diabetic retinopathy.

Authors:  G H Bresnick; M Palta
Journal:  Arch Ophthalmol       Date:  1987-05

6.  A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy.

Authors:  K Holopigian; W Seiple; M Lorenzo; R Carr
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-09       Impact factor: 4.799

Review 7.  Current electrophysiology in ophthalmology: a review.

Authors:  Blair Young; Eric Eggenberger; David Kaufman
Journal:  Curr Opin Ophthalmol       Date:  2012-11       Impact factor: 3.761

Review 8.  Overview of epidemiologic studies of diabetic retinopathy.

Authors:  Barbara Eden Kobrin Klein
Journal:  Ophthalmic Epidemiol       Date:  2007 Jul-Aug       Impact factor: 1.648

Review 9.  Role of Electrophysiology in the Early Diagnosis and Follow-Up of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Andrea Barbato; Alessio Stefanucci; Giuseppe Buomprisco
Journal:  J Diabetes Res       Date:  2015-05-05       Impact factor: 4.011

10.  Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device.

Authors:  Motonobu Fukuo; Mineo Kondo; Akira Hirose; Harumi Fukushima; Kengo Ikesugi; Masahiko Sugimoto; Kumiko Kato; Yasuko Uchigata; Shigehiko Kitano
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

View more
  3 in total

1.  Oscillatory Potentials in Achromatopsia as a Tool for Understanding Cone Retinal Functions.

Authors:  Giulia Righetti; Melanie Kempf; Christoph Braun; Ronja Jung; Susanne Kohl; Bernd Wissinger; Eberhart Zrenner; Katarina Stingl; Krunoslav Stingl
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

2.  Protective role and molecular mechanism of action of Nesfatin-1 against high glucose-induced inflammation, oxidative stress and apoptosis in retinal epithelial cells.

Authors:  Haiyan Sun; Huahui Zhao; Zhipeng Yan; Xiaokun Liu; Pengfei Yin; Jun Zhang
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

3.  Preventive Efficacy of an Antioxidant Compound on Blood Retinal Barrier Breakdown and Visual Dysfunction in Streptozotocin-Induced Diabetic Rats.

Authors:  Alessio Canovai; Rosario Amato; Alberto Melecchi; Massimo Dal Monte; Dario Rusciano; Paola Bagnoli; Maurizio Cammalleri
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.